February 2, 2023 Posted by: GMI-Co Category: Economics No Comments Novo Nordisk and Eli Lilly are both working to ramp up capacity and insurance coverage for anti-obesity drugs. Leave a Reply Cancel reply post a comment app.gmi-co.com Looking for growth capital? Contact GMI Capital for Financing Impact, Bridging Gaps, Building Wealth Contact Us